© 1986 Oxford University Press
research-article |
The Influence of Recombinant DNA-Derived Human and Murine Gamma Interferons on Mouse Hepatic Drug Metabolism
Department of Biochmical Pharmacology and Toxicology, University of Utah Salt Lake City, Utah 84112
The Influence of Recombinant DNA-Derived Human and Murine Gamma Interferons on Mouse Hepatic Drug Metabolism. FRANKLIN, M. R., AND FINKLE, B. S. (1986) Fundam. Appl Toxicol. 7, 165-169. Human gamma interferon given for up to 5 days by subcutaneous infusion or intraperitoneal injection did not significantly alter mouse hepatic microsomal oxidative drug-metabolizing enzyme activities. In contrast, murine gamma interferon and human alpha interferon given for 5 days at the same dose (107 units/kg) caused 25 and 50% decreases, respectively, in hepatic microsomal cytochrome P-450 concentrations. The human alpha interferon-induced decline in cytochrome P-450 was accompanied by a significant drop in p-vnitroanisole demethylase activity and significant elevations in serum alanine aminotransferase and cytosolic glutathione S-transferase activities. An elevation in glutathione-5-transferase was the only significant change found following human gamma interferon administration. Microsomal UDP-glucuronosyltrans-ferase activity was unaffected by any interferon.